2 key stock picks for reliable passive income

I’m looking at stocks that can deliver reliable passive income to complement my growth picks, and I think I’ve found them.

| More on:
A couple celebrating moving in to a new home

Image source: Getty Images

As an investor who is primarily focused on growth and disruption, picking solid and reliable passive income stocks can seem somewhat underwhelming. That is why it is important to remember that when we talk about passive income stocks, we are talking about companies that deliver a dividend purely by virtue of owning them. This is a powerful selling point for an investor, even for growth-focused investors like myself, as the income received can also be reinvested.

It’s worth noting that high dividend yields don’t automatically mean superiority, as we are looking for reliable passive income that can be reinvested — and too high of a yield can be considered a risk to long-term company prospects.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

Phoenix Group Holdings

My first pick is insurance and savings giant Phoenix Group Holdings (LSE:PHNX).

Like much of the market, Phoenix’s share price has come under selling pressure since its peaks in 2021 and, despite a strong start to the year, is currently trading at 628p, 17% off its 52-week high.

Even taking into account the current volatility in the market, this drop looks overdone, with Phoenix once again declaring annual growth in free cash flow, new business and profitability.

Phoenix Group boasts an impressive track record of stable growth in both profitability and dividends, providing shareholders with a whopping 8% dividend yield. This meant the company boosted its investors’ coffers with 3% organic dividend growth on the year, and keeps it in line with the sustainable 4% compound annual growth rate (CAGR) in dividends it has provided shareholders since 2011.

My one concern here would be the maturity of the underlying businesses owned by Phoenix and whether such levels of growth can be maintained under stricter market conditions. That being said, Phoenix has a rich history of smart strategic acquisitions, and so I certainly wouldn’t bet against its ability to maintain this level of income over the coming years.

GlaxoSmithKline

Next up, a potentially surprising choice, in GlaxoSmithKline (LSE:GSK), currently trading at 1,771p.

A £90bn-cap pharma giant wouldn’t normally be considered a surprise pick, but growth in revenue for Glaxo has been relatively slow, and it has not raised dividends since 2014, keeping the yield at a steady 4.5%. Nonetheless, that is still well above the current FTSE 100 average yield of 3.3%.

Glaxo also had a strong first quarter with revenue and net income increasing by 32% and 68% year on year respectively. This has been reflected somewhat in performance with its share price demonstrating considerable relative strength in the face of a protracted sector pullback.

Moreover, the company operates in a sector that tends to outperform both going in and coming out of recession cycles which goes some way to offsetting growing pains.

Given the pressure the biotech sector has come under, coupled with GlaxoSmithKline’s cash position, there also appears to be some attractive merger and acquisition possibilities to shore up its pipeline. Overall, GSK will be a key pick for my passive income portfolio going forward.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Joshua Kalinsky has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Should you invest the value of your investment may rise or fall and your Capital is at Risk. Before investing your individual circumstances should be considered, so you should consider taking independent financial advice.

More on Investing Articles

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

£10,000 invested in BT shares 10 years ago is now worth this much

It's painful to remember that BT shares reached over £10 at the peak of the dot com bubble in 1999.…

Read more »

Close-up Of A Piggybank With Eyeglasses And Calculator On Desk
Investing Articles

Is now the time to buy bank shares?

Our writer considers whether bank shares could be a bargain buy for his portfolio right now -- or a potential…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

After steep falls, are Royal Mail shares a steal?

Royal Mail shares have more than halved since peaking a year ago. After months of steep falls, this popular stock…

Read more »

Young Woman Drives Car With Dog in Back Seat
Investing Articles

Dirt-cheap, 1 of my best stocks to buy also pays an above-average dividend!

This Fool has decided to buy the shares on his best stocks to buy now list with the shares looking…

Read more »

Light bulb with growing tree.
Investing Articles

The AFC share price just tanked! Is now the time to buy?

The AFC share price fell nearly 10% on Wednesday after the H1 revenue announcement. So, should I add this stock…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

These shares have been growing dividends for decades. I’d buy!

Our writer considers the merits for his portfolio of buying two shares with a track record of growing dividends.

Read more »

Close-up of British bank notes
Investing Articles

Is the M&G dividend yield heading to 10%?

As the M&G dividend yield heads towards double digits, out writer explains why he is considering buying more of the…

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

3 top dividend shares to buy now

With weakness in the markets, I reckon it's a good time to search for top dividend shares to buy now.

Read more »